Goy J J, Stauffer J C, Yusoff Z, Wong A R, Owlya R, Perret F, Siegenthaler M, Savcic M, Ménétrey R, Seydoux C
Cardiology Service, Clinique Cecil, Lausanne, Switzerland.
Catheter Cardiovasc Interv. 2006 Feb;67(2):265-7. doi: 10.1002/ccd.20607.
We report the first experience obtained with the new Intrasept device. We attempted to treat 35 patients with a mean age of 43 +/- 21 years. The mean size of the defect was 17/15 mm. It was successfully closed in 31 patients. In the remaining four the device could not be stabilized because of excessive defect size. A small residual shunt was present immediately following implantation in three patients. No complications occurred during the procedure and at 6 months, 31 patients had an uneventful outcome. Only one patient had a small residual shunt. No thrombus, embolization, or device fracture was documented during a mean follow-up of 17 +/- 11 months. Percutaneous closure of ASD ostium secundum is feasible with the Intrasept device with a high success rate and very good medium-term outcome. Our initial experience and results were excellent with small to medium size defects, however, large defects (>20 mm) remain challenging.
我们报告了使用新型Intrasept装置获得的首例经验。我们试图治疗35例平均年龄为43±21岁的患者。缺损的平均大小为17/15毫米。31例患者成功闭合。其余4例因缺损过大，装置无法稳定。3例患者植入后立即出现小的残余分流。手术过程中及术后6个月均未发生并发症，31例患者预后良好。仅1例患者有小的残余分流。在平均17±11个月的随访中，未记录到血栓形成、栓塞或装置断裂。使用Intrasept装置经皮闭合继发孔型房间隔缺损是可行的，成功率高，中期预后良好。我们对于中小尺寸缺损的初步经验和结果非常好，然而，大尺寸缺损（>20毫米）仍然具有挑战性。
